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Socioeconomic determinants of 
sarcopenic obesity and frail obesity 
in community-dwelling older 
adults: The Seniors-ENRICA Study
Belén Moreno-Franco1, Raúl F. Pérez-Tasigchana2,3, Esther Lopez-Garcia2,4, Martin Laclaustra1, 
Juan L. Gutierrez-Fisac2, Fernando Rodríguez-Artalejo2,4 & Pilar Guallar-Castillón2,4
Information on the association between socioeconomic status (SES) throughout life and sarcopenic 
obesity is scarce, whereas no study has been focused on the association between SES and frail obesity. 
This analysis estimated the prevalence of sarcopenic obesity and frail obesity, and their associations 
with SES in older adults. Data were collected in 2012 from 1,765 non-institutionalized individuals 
aged ≥65 participating in the Seniors-ENRICA study in Spain, by using standardized techniques and 
equipment. SES throughout life was evaluated with the father’s occupation, participant’s educational 
level, former own occupation, and current poor housing condition. Overall, 17.2% of participants had 
sarcopenic obesity, and 4.0% frail obesity. No association was found between SES and sarcopenic 
obesity. In contrast, the prevalence of frail obesity was higher in those with lower education, having 
worked in manual job, and currently having poor housing condition. Having ≥1 social disadvantages 
throughout life was associated with higher prevalence of frail obesity. The prevalence of this disorder 
increased by 1.49 (95% CI: 1.21–1.85) times for each social disadvantage added. The OR (95% CI) of 
frail obesity was 3.13 (1.71–5.7) for those having 3 or 4 vs. 0 or 1 social disadvantages, implying a more 
complex process beginning early in life.
The aging process is associated with loss of skeletal muscle mass (SMM) and strength, a phenomenon known 
as sarcopenia, which in turn is linked to higher risk of functional impairment and death1. Frailty is a geriatric 
syndrome characterized by loss of physiological and functional reserve that increases the vulnerability to even 
minor stressors (e.g.: dehydration, a cold, diarrhea, etc.)2. As a result, frailty is associated with greater risk of falls, 
hospitalization, disability, and death3. Sarcopenia can be in the pathophysiological pathway to frailty, but they are 
independent syndromes.
Simultaneously with the process of sarcopenia that occurs in the elderly, there is an increase in fat mass, that 
is reflected in the high prevalence of obesity in recent decades worldwide4. Obesity induces a pro-inflammatory 
state through the release of adipokines such as IL-6 and TNF-α which can increase muscle loss, and also modify 
muscle composition and quality, potentially affecting its functionality5–7. Thus, despite a low body mass index 
(BMI) it is still a predictor of sarcopenia8, also excess of adiposity couples with sarcopenia, characterizing the 
so called “sarcopenic obesity”. It has been postulated that the synergistic association between sarcopenia and 
obesity may potentiate the effects of both syndromes separately, playing a probable role in the increased risk of 
cardiovascular disease and even of mortality. Nevertheless the results are still contradictory and dependent on the 
heterogeneity of the definitions of these syndromes9,10. In addition, although frailty is considered a wasting dis-
order, it can coexist with obesity as “frail obesity”. In fact, so far today, longitudinal studies have only considered 
obesity as a determinant of frailty7,11,12, without considering frail obesity as a proper entity. Previously reported 
prevalence of sarcopenia and sarcopenic obesity in the Spanish population ranged between 13.8 and 24.1%, and 
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11.0 and 14.9% respectively13,14. In addition, prevalence of frailty found in Spanish studies spans from 8.4 to 16.9, 
which makes it a potential problem for the aging Spanish demographics15–17.
Inequalities in socioeconomic status (SES) throughout life are associated with increased risk of morbidity and 
mortality18–22, and can lead to poor health outcomes later in life. It is well known that SES influences obesity23. 
Likewise, its relationship with sarcopenia and frailty has previously been studied24,25. However, information on 
the association between SES throughout life and sarcopenic obesity is scarce26, whereas no study has been focused 
on the association between SES and frail obesity. So, this study assessed the prevalence of sarcopenic and frail 
obesity, and its association with SES throughout life, in community-dwelling older adults.
Methods
Study design and participants. We used cross-sectional data from the second wave of the Seniors-
ENRICA cohort7,27. Briefly, this cohort was set up in 2008–2010 with 3,289 individuals, representative of the 
non-institutionalized Spanish population aged ≥6027. Participants were followed up to 2012, when a second 
wave of data collection was performed. Data in this second wave were collected during a telephone interview on 
socio-demographic variables, lifestyle and morbidity. There were two subsequent home visits to obtain blood and 
urine samples, perform a physical examination, record habitual diet, and prescribed medication. After excluding 
95 participants who died, 2,519 individuals provided updated information; of them, we excluded 264 participants 
aged < 65, and 490 with missing data on anthropometry, impedanciometry, or SES components. Thus, the anal-
yses were conducted with 1,765 subjects.
The Seniors-ENRICA study was approved by the Clinical Research Ethics Committee of La Paz University 
Hospital. All research was performed in accordance with relevant guidelines, and study participants gave 
informed written consent.
Study variables. Weight, height and percentage of body fat (%BF) were measured in all participants. Height 
was measured twice with a portable extendable stadiometers (model Ka We 44 444 Seca). Weight and %BF was 
estimated by bioelectrical impedance analysis (BIA) (Tanita®SC-240MA, Tanita Corp., Tokyo, Japan). BMI was 
calculated as weight in kg divided by height in meters squared.
SMM (kg) was calculated with the equation developed by Janssen et al.28: ([Height2/Resistance − 0.401] + [sex × 
3.825] + [age × −0.071]) + 5.102, where height is given in cm, resistance in ohms (from BIA), sex as 1 for men 
and 0 for women, and age in years. Skeletal muscle mass index (SMI) was estimated by dividing SMM by height in 
meters squared. Sex-specific quintiles of SMI were created: ≤9.21; 9.22–10.06; 10.07–10.75; 10.76–11.67; ≥11.69 
for men, and ≤7.07; 7.08–7.70; 7.71–8.31; 8.32–9.18; ≥9.19 for women. Sarcopenia was defined as the lower two 
quintiles of SMI29. Sex-specific quintiles of %BF were: ≤22.30; 22.40–25.40; 25.44–28.70; 28.80–32.60; ≥32.68 
for men, and ≤31.80; 31.82–35.70; 35.80–39.10; 39.20–42.60; ≥42.70 for women. Participants were classified as 
obese, when they were in the upper two quintiles of %BF.
Frailty was defined as having at least three of the five Fried’s criteria30: (1) exhaustion: any of the following 
responses to two questions taken from the Center for Epidemiologic Studies Depression Scale31: “I feel that any-
thing I do is a big effort” or “I feel that I cannot keep on doing things” at least 3–4 days a week; (2) weight loss: 
unintentional loss of ≥4.5 kg of body weight in the preceding year; (3) low physical activity: walking ≤2.5 h/week 
in men or ≤2 h/week in women31; (4) weakness: the cohort-specific lowest quintile of grip strength adjusted for 
sex and BMI32. Strength was measured with a Jamar dynamometer, previously calibrated, and the highest value in 
two consecutive measurements was used in the analyses; and (5) slow walking speed: the lowest cohort-specific 
quintile in the three-meter walking speed test, adjusted for sex and height33.
Based on the aforesaid cross-tabulated bounds of %BF and SMI, sarcopenic obesity was diagnosed when par-
ticipants were in the upper two quintiles of %BF and in the lower two quintiles of SMI29. Likewise, frail obesity 
was diagnosed when participants were in the upper two quintiles of %BF and met ≥3 Fried criteria.
Socioeconomic status. Father’s occupation, educational level, former own occupation (almost all partici-
pants were currently retired), and current housing conditions were considered as proxies for SES, corresponding 
respectively to their SES in different periods in life: childhood, youth, adulthood, and late life. Father’s occupa-
tion and formal own occupation (corresponding to the current or last job held) were classified according to the 
National Classification of Occupations in Spain, and grouped into manual and non-manual jobs. Housewives 
were assigned the occupation of their husbands. Educational level was assessed as the highest level reached (pri-
mary or lower, secondary, and university). Individuals were identified as having housing disadvantage when they 
lived in a house with at least one of the following poor conditions: no elevator in a walk-up building, feeling cold 
often, or having no heating. Having housing disadvantage was considered as a proxy for current low SES. Having 
at least one social disadvantage throughout life was considered when they met at least one of the following con-
ditions: father’s manual occupation, primary studies or lower, former own manual occupation, and living in poor 
housing conditions. A scale was constructed to assess the accumulation of social disadvantages throughout life by 
adding one point for each previous criteria (range 0–4).
Other variables. Apart from sex and age, the interview collected participant’s own-reported physician- 
diagnosed diseases: cardiovascular diseases (heart attack, stroke, heart failure or atrial fibrillation), asthma or 
chronic bronchitis, osteoarticular diseases (osteoarthritis, rheumatoid arthritis or hip fracture), cancer at any site, 
and depression requiring drug treatment. Individuals also reported self-rated health and their health-related quality 
of life (HRQL) using the SF-12 questionnaire from which mental and physical scores were calculated.
Statistical analysis. The prevalence of sarcopenic and frail obesity was calculated and the chi-square test 
was used to assess age- and sex-differences. Mean and standard deviation (SD) were used to describe charac-
teristics of the participants in the study according to SES components. We used logistic regression to assess the 
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association of each social disadvantage throughout life with sarcopenic and frail obesity. Regression models were 
adjusted for age and sex. We used the SES throughout life as a continuous variable to assess the association 
between the increase in one social disadvantage and sarcopenic obesity or frail obesity. In addition, this scale was 
divided into three categories (0 or 1, 2, 3 or 4 disadvantages), being 0 or 1 the reference category. A p for linear 
trend was calculated by modelling the independent variable as continuous. Results are presented as odds ratios 
(OR) and their 95% confidence interval (CI). We conducted sensitivity analyses with a modified definition of sar-
copenic obesity and frail obesity, by considering obesity as BMI ≥ 30 kg/m2. Analyses were performed with IBM 
SPSS for Windows, version 22.0 (Armonk, NY; IBM Corp.), and p < 0.05 was considered statistically significant.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
Results
The sample consisted of 1,765 participants, 830 men and 935 women, ranging from 65 to 97 years old. From the 
total sample, 17.2% (95% CI: 15.4–19.0) had sarcopenic obesity. No differences were found in the prevalence of 
this condition between men and women, or age groups (Table 1). Sensitivity analysis showed that when BMI 
criterion was used (≥30 kg/m2) instead of %BF to be considered obese, the prevalence for sarcopenic obesity 
was 5.9% (95% CI: 4.7–7.0). A total of 4.0% (95% CI: 3.1–4.9) of participants had frail obesity. The frequency was 
higher in women and those aged 75 years-old or above (Table 1). Sensitivity analysis showed that when obesity 
was defined as BMI ≥ 30 kg/m2, the prevalence of frail obesity was similar, 4.1% (95% CI: 3.2–5.0). Both condi-
tions partially overlapped. Among those with sarcopenic obesity, 8.7% were also obese frail. Among obese frail, 
36.6% were also obese sarcopenic.
From the total sample, 32.2% (95% CI: 30.0–34.4) had a father with manual occupation, 45.5% (95% CI: 
43.2–47.8) had primary or lower educational level, 38.1% (95% CI: 35.9–40.4) had former own manual occu-
pation, and 35.9% (95% CI: 33.6–38.1) had at least one poor housing condition. We noticed a higher frequency 
of women in all these groups (53.8%, 61.9%, 56.2% and 57.8% respectively). Those in the lowest socioeconomic 
groups were observed to have worse auto-perceived health, lower HRQL, and greater morbidity. There was a large 
difference in the frequency of osteoarticular diseases between those with primary or university studies (56.7% vs. 
36.0%), and between those with and without housing disadvantage (54.7% vs. 45.6%). Likewise, depression was 
more frequently reported by those with primary education compared with those with university studies (12.4% 
vs. 1.5%). No differences were found in the prevalence of sarcopenic obesity across SES categories. However, the 
prevalence of frail obesity was higher in all the lowest socioeconomic groups. The most pronounced differences 
occurred between those with primary and university education (5.9 vs. 1.5) (Table 2).
Once adjusted for age and sex, none of SES variables were associated with sarcopenic obesity. On the con-
trary, frail obesity was associated with older age (OR 2.71, 95% CI: 1.67–4.40), being a woman (OR 4.49, 95% 
CI: 2.39–8.44), lower education (OR 2.66, 95% CI: 1.12–6.32), former own manual occupation (OR 1.83, 95% 
CI: 1.13–2.98), and having at least one poor housing condition (OR 1.77, 95% CI: 1.09–2.88). Having at least 
one social disadvantage throughout life also increased the prevalence of having frail obesity (OR 3.45, 95% CI: 
1.24–9.61). The likelihood of suffering from frail obesity was increased by 1.49 (95% CI: 1.21–1.85) times for each 
social disadvantage added (Table 3). Likewise, having 3 or 4 social disadvantages obtained an OR of 3.13 (95% CI: 
1.71–5.70) when comparing to 0 or 1 disadvantages (Table 4).
Discussion
This cross-sectional analysis conducted with a population-based study in Spain, showed a prevalence of sar-
copenic obesity of 17.2%, and a prevalence of frail obesity of 4.0%. No association was found between SES and 
sarcopenic obesity. In contrast, lower educational level, having worked in manual jobs, and having poor housing 
conditions were associated with frail obesity. In addition, having at least one social disadvantage throughout life 
substantially increased the prevalence of having frail obesity.
Few studies have determined the prevalence of sarcopenic obesity in Spain, reporting a slightly lower fre-
quency (14.9% vs. 17.2%), also using sex specific quintiles of %BF and SMI14. In Europe, a study performed 
between 2011 and 2012 showed, by means of predictive equations, that 11.0% of the 1,865 Spanish participants 
Sarcopenic obesity Frail obesity
N n % N n %
Overall 1730 298 17.2 1764 71 4.0
<75 1144 199 17.4 1168 30 2.6
≥75 586 99 16.9 596 41 6.9a
Men 808 147 18.2 829 12 1.4
<75 549 100 18.2 565 5 0.9
≥75 259 47 18.1 264 7 2.6a
Women 922 151 16.4 935 59 6.3b
<75 595 99 16.6 603 25 4.1
≥75 327 52 15.9 332 34 10.2a
Table 1. Frequency of sarcopenic and frail obesity by sex and age, Seniors-ENRICA cohort (2012). Notes: 
Statistically significant between groups (p < 0.05): a<75 vs. ≥75; bMen vs. Women.
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aged ≥65 had sarcopenic obesity13. In France, a lower prevalence was also found from the analysis of 1,308 
institutionalized healthy women aged ≥75. Of them, 2.8% were identified as obese sarcopenic34. In the US, a 
cross-sectional analysis performed with 2,287 subjects aged 60 and older from the National Health and Nutrition 
Examination Survey (NHANES 1999–2004) reported that 10.4% were obese sarcopenic. In this case, waist cir-
cumference was used to assess obesity, and appendicular SMM was measured by dual-energy X-ray absorptiom-
etry (DXA)35. Finally, data from the Nutrition as a Determinant of Successful Aging (NuAge) Study in Canada, 
with 904 community-dwelling individuals aged between 68 and 82 showed a prevalence of 18.8% in men, and 
10.8% in women (the European Working Group on Sarcopenic in Older People criteria were used for sarcopenia 
diagnosis, and body composition was assessed by DXA)36.
Marked differences exist in the prevalence among studies. Comparison of results on sarcopenic obesity is 
still somewhat complex due to the heterogeneity of the methods and cut-off points used to assess both SMM 
and obesity. Since first defined sarcopenia in 1998 by Baumgartner et al. as appendicular SMM (kg/m2) less than 
two standard deviations below the sex-specific mean in a young reference group37, several definitions have been 
proposed relying on muscle mass, but also on strength and physical performance38. Coupled with this problem, 
the lack of consensus in determining high fat mass makes sarcopenic obesity prevalence vary widely39. In fact, in 
our analysis it ranged from 17.2% using %BF to 5.8% using BMI as diagnostic criteria. However, prevalence of 
frail obesity was similar when using BMI ≥ 30 kg/m2. The use of BMI as an indicator of obesity in the elderly has 
been questioned due to changes in body composition with ageing, since it does not take into account the loss of 
muscle mass40. On the other hand, the utilization of computed tomography and magnetic resonance (considered 
as the gold standard methods in research), is of limited use in epidemiological studies due to the emission of 
radiation and high cost, being DXA and BIA (considered to be a portable alternative to DXA) the most common 
instruments to assess sarcopenic obesity in general populations.
Influence of SES on health has been widely reported. It is known that, social inequalities begin in childhood, 
and can be sustained throughout life, but the way they impact negatively on some health events later in life 
remains unclear. Educational level, as a SES indicator in youth, constitutes a strong predictor of future type of 
employment, and it is considered the socioeconomic factor with most influence on health. Thus, educational 
inequalities have been related with a worse HRQL in the elderly41. Likewise, studies conducted both in Europe 
and USA, have reported an increased risk of mortality in those with lower educational level21,22. Among middle 
age participants, manual work could involve greater exposure to certain conditions, which may influence phys-
ical and mental health in the elderly18,19, as well as in achieving a better HRQL after labour market42. Midlife 
adversities like low occupational position or high job strain have been associated with post-retirement depressive 
symptoms18. Besides, higher midlife occupational physical activity levels, have been related to major risk of dis-
ability later in life19. Finally, it is probable that all previously mentioned factors could influence people to have 
less access to a better equipped house later in life. There are grounds for believing that older adults are probably 
more exposed to certain social disadvantage like lower purchasing power. It is also known that, retired people are 
at greater risk of physical disability and frailty43, and those conditions increase in those with fewer resources20.
Some information on SES and its relationship with sarcopenia and frailty is available24,25. Though, data study-
ing this association with sarcopenic obesity is scarce26, whereas no study has evaluated its link with frail obesity. 
Moreover, SES throughout life has never been assessed. We observed no association between sarcopenic obesity 














N = 673 No N = 1132 Yes N = 633
Sociodemographic
Age (years) 72.9 (5.8) 72.3 (6.0) 71.9 (5.6) 71.5 (5.8) 73.6 (5.9) 72.7 (6.0) 72.8 (5.8) 72.8 (6.0) 72.6 (5.8)
Women (%) 52.6 53.8 38.8 45.7 61.9 51.0 56.2 50.3 57.8
Morbidity
Self-perceived health (%)
Excellent/Very good/Good 66.9 60.3 81.9 75.5 53.0 68.6 58.5 66.8 61.1
Regular/Bad 33.1 39.7 18.1 24.5 47.0 31.4 41.5 33.2 38.9
Physical health score (SF-12) 45.2 (12.0) 43.6 (12.4) 48.0 (10.8) 46.7 (11.2) 42.5 (12.7) 45.6 (11.8) 43.3 (12.7) 44.9 (12.0) 44.4 (12.6)
Mental health score (SF-12) 53.2 (10.6) 52.8 (11.1) 55.2 (8.4) 54.2 (9.0) 51.7 (12.1) 53.5 (10.4) 52.4 (11.4) 53.8 (10.4) 51.8 (11.3)
Cardiovascular disease (%)a 6.4 8.3 7.0 7.8 6.7 6.8 7.3 7.2 6.7
Asthma or chronic bronchitis (%) 11.5 12.7 9.8 10.0 13.5 11.9 11.8 11.1 13.3
Osteoarticular diseases (%)b 48.3 50.1 36.0 43.2 56.7 46.5 52.7 45.6 54.7
Cancer (%) 3.1 3.5 3.6 2.7 3.3 2.9 3.7 2.6 4.4
Depression (%) 8.4 9.7 1.5 7.5 12.4 7.3 11.3 8.0 10.3
Sarcopenic obesity (%) 17.0 17.1 19.1 15.6 16.8 17.2 16.8 18.0 15.2
Frail obesity (%) 3.6 4.9 1.5 1.9 5.9 3.0 5.6 3.1 5.7
Table 2. Sociodemographic and morbidity characteristics of study participants by socioeconomic status 
components, Seniors-ENRICA cohort (2012). Continuous variables are expressed as mean ± SD. aSelf-reported 
heart attack, stroke, heart failure or atrial fibrillation. bSelf-reported osteoarthritis, rheumatoid arthritis or hip 
fracture.
www.nature.com/scientificreports/
5SCIEnTIFIC REPORTS |  (2018) 8:10760  | DOI:10.1038/s41598-018-28982-x
and any of the SES variables. These data are in line with those reported by Tyrovolas et al. who found similar 
results when assessing SES as educational level and wealth26. Our results showed an association between being 
in social disadvantage and suffering from frail obesity. Interestingly, all the SES determinants were positively and 
statistically associated with frail obesity, except father’s occupation, that also is the furthest in the causal pathway. 
Moreover, those with at least one social disadvantage throughout life presented a probability up to threefold 
higher risk of being obese frail than those without any social disadvantage.
We observed that sarcopenic obesity appears more frequently among those with higher levels of education, 
while frail obesity does among those with just primary studies. It is likely that more educated subjects may have 
lower muscle mass, probably because they have more sedentary jobs. However, it is plausible that their SES 
allowed them to access better health services, and associates better nutritional habits and self-care which may 
have avoided the frailty characteristic loss of function. This reason justifies that education, as a determinant of 
health, should be part of an integral form in the new approach to public health.
To the best of our knowledge, this is the first study to evaluate the association between frail obesity and SES 
determinants in community-dwelling older adults. It has the strength of having been carried out by means of stand-
ardized protocols. Additionally, a basic adjustment was performed. However, it has also several limitations. The main 
one is the cross-sectional nature of the data that may suffer from survival, recall, and selection biases. Owing to the 
difficulty obtaining self-reported information on income among the elderly, we did not consider this variable, even 
though, the best way to measure SES is probably combining education, occupation, and income. In addition, a small 
number of cases in some stratified groups were found, especially for frailty. Also, the use of specific quintiles in our 





n OR (95% CI)a n OR (95% CI)a
Age
<75 1144 199 Ref. 1168 30 Ref.
≥75 586 99 0.97 (0.74–1.26) 596 41 2.71 (1.67–4.40)
Sex
Men 808 147 Ref. 829 12 Ref.
Women 922 151 0.88 (0.67–1.14) 935 59 4.49 (2.39–8.44)
Father’s occupation
Non-manual 1168 201 Ref. 1195 43 Ref.
Manual 562 97 1.00 (0.77–1.31) 569 28 1.38 (0.84–2.26)
Educational level
University 382 74 Ref. 389 6 Ref.
Secondary 406 64 0.78 (0.54–1.13) 414 8 1.17 (0.40–3.43)
≤Primary 942 160 0.89 (0.65–1.21) 961 57 2.66 (1.12–6.32)
Former own occupation
Non-manual 1072 186 Ref. 1091 33 Ref.
Manual 658 112 0.98 (0.76–1.27) 673 38 1.83 (1.13–2.98)
At least one poor housing condition
No 1110 203 Ref. 1131 35 Ref.
Yes 620 95 0.81 (0.62–1.06) 633 36 1.77 (1.09–2.88)
At least one social disadvantage throughout life
No 352 63 Ref. 358 4 Ref.
Yes 1378 235 0.96 (0.71–1.31) 1406 67 3.45 (1.24–9.61)
The increase of one social disadvantage 1730 — 0.96 (0.87–1.07) 1764 — 1.49 (1.21–1.85)
Table 3. Association between presenting sarcopenic obesity or frail obesity and sociodemographic 
characteristics and socioeconomic status, Seniors-ENRICA cohort (2012). aModel adjusted for age (as a 
continuous variable) and sex (except for the stratification variable).
Number of social disadvantages throughout life
0/1 2 3/4 p-trend
Sarcopenic obesity 153/850 72/458 73/422
OR (95% CI)a Ref. 0.86 (0.63–1.17) 0.97 (0.71–1.32) 0.726
Frail obesity 18/868 21/465 32/431
OR (95% CI)a Ref. 1.89 (0.98–3.61) 3.13 (1.71–5.70) <0.001
Table 4. Association between the number of social disadvantages throughout life and the probability of 
suffering from sarcopenic obesity or frail obesity, Seniors-ENRICA cohort (2012). Notes: OR = Odds ratio; 
IC = Confidence interval. aModel adjusted for age (as a continuous variable) and sex.
www.nature.com/scientificreports/
6SCIEnTIFIC REPORTS |  (2018) 8:10760  | DOI:10.1038/s41598-018-28982-x
Conclusions
This study emphasizes the need for consensual criteria in the diagnosis of these syndromes, and to point out the 
need for an agreement on the definitions, cut-off points, and measurement methods, in order to be used in gen-
eral populations of older adults. At the same time, this research highlights the special importance of education 
and SES throughout life in the prevalence of frailty related to obesity, but not for sarcopenic obesity. This probably 
implies that for frail obesity, determinants could have been operating for a long period of time, implying a com-
plex process beginning early in life.
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